<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE trials [
<!ELEMENT trials (trial+)>

<!ELEMENT trial (main,contacts,countries,criteria,health_condition_code,health_condition_keyword,intervention_code,
          intervention_keyword,primary_outcome,secondary_outcome,secondary_sponsor,secondary_ids,source_support,ethics_reviews)>

<!ELEMENT main (trial_id,utrn?,reg_name,date_registration,primary_sponsor,public_title,acronym?,scientific_title,scientific_acronym?,
          date_enrolment,type_enrolment,target_size,recruitment_status,url?,study_type,study_design,phase,hc_freetext?,i_freetext?,results_actual_enrolment,results_date_completed,results_url_link,results_summary,           results_date_posted,results_date_first_publication,results_baseline_char,results_participant_flow,results_adverse_events,results_outcome_measures,results_url_protocol,results_IPD_plan, results_IPD_description)>
<!ELEMENT trial_id (#PCDATA)>
<!ELEMENT utrn (#PCDATA)>
<!ELEMENT reg_name (#PCDATA)>
<!ELEMENT date_registration (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT primary_sponsor (#PCDATA)>
<!ELEMENT public_title (#PCDATA)>
<!ELEMENT acronym (#PCDATA)>
<!ELEMENT scientific_title (#PCDATA)>
<!ELEMENT scientific_acronym (#PCDATA)>
<!ELEMENT date_enrolment (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT type_enrolment (#PCDATA)>
<!ELEMENT target_size (#PCDATA)>
<!ELEMENT recruitment_status (#PCDATA)><!-- Pending,Recruiting,Suspended,Complete,Other -->
<!ELEMENT url (#PCDATA)>
<!ELEMENT study_type (#PCDATA)><!-- interventional,observational -->
<!ELEMENT study_design (#PCDATA)>
<!ELEMENT phase (#PCDATA)>
<!ELEMENT hc_freetext (#PCDATA)>
<!ELEMENT i_freetext (#PCDATA)>
<!ELEMENT results_actual_enrolment (#PCDATA)>
<!ELEMENT results_date_completed (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_url_link (#PCDATA)>
<!ELEMENT results_summary (#PCDATA)>
<!ELEMENT results_date_posted (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_date_first_publication (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_baseline_char (#PCDATA)>
<!ELEMENT results_participant_flow (#PCDATA)>
<!ELEMENT results_adverse_events (#PCDATA)>
<!ELEMENT results_outcome_measures (#PCDATA)>
<!ELEMENT results_url_protocol (#PCDATA)>
<!ELEMENT results_IPD_plan (#PCDATA)>
<!ELEMENT results_IPD_description (#PCDATA)>


<!ELEMENT contacts (contact+)>
<!ELEMENT contact (type,firstname,middlename,lastname,address,city,country1,zip,telephone,email,affiliation)>
<!ELEMENT type (#PCDATA)><!-- Public,Scientific -->
<!ELEMENT firstname (#PCDATA)>
<!ELEMENT middlename (#PCDATA)>
<!ELEMENT lastname (#PCDATA)>
<!ELEMENT address (#PCDATA)>
<!ELEMENT city (#PCDATA)>
<!ELEMENT country1 (#PCDATA)>
<!ELEMENT zip (#PCDATA)>
<!ELEMENT telephone (#PCDATA)>
<!ELEMENT email (#PCDATA)>
<!ELEMENT affiliation (#PCDATA)>

<!ELEMENT countries (country2+)>
<!ELEMENT country2 (#PCDATA)>

<!ELEMENT criteria (inclusion_criteria,agemin,agemax,gender,exclusion_criteria)>
<!ELEMENT inclusion_criteria (#PCDATA)>
<!ELEMENT agemin (#PCDATA)>
<!ELEMENT agemax (#PCDATA)>
<!ELEMENT gender (#PCDATA)>
<!ELEMENT exclusion_criteria (#PCDATA)>

<!ELEMENT health_condition_code (hc_code+)>
<!ELEMENT hc_code (#PCDATA)>

<!ELEMENT health_condition_keyword (hc_keyword+)>
<!ELEMENT hc_keyword (#PCDATA)>

<!ELEMENT intervention_code (i_code+)>
<!ELEMENT i_code (#PCDATA)>

<!ELEMENT intervention_keyword (i_keyword+)>
<!ELEMENT i_keyword (#PCDATA)>

<!ELEMENT primary_outcome (prim_outcome+)>
<!ELEMENT prim_outcome (#PCDATA)>

<!ELEMENT secondary_outcome (sec_outcome+)>
<!ELEMENT sec_outcome (#PCDATA)>

<!ELEMENT secondary_sponsor (sponsor_name+)>
<!ELEMENT sponsor_name (#PCDATA)>

<!ELEMENT secondary_ids (secondary_id+)>
<!ELEMENT secondary_id (sec_id,issuing_authority)>
<!ELEMENT sec_id (#PCDATA)>
<!ELEMENT issuing_authority (#PCDATA)>

<!ELEMENT source_support (source_name+)>
<!ELEMENT source_name (#PCDATA)>

<!ELEMENT ethics_reviews (ethics_review+)>
<!ELEMENT ethics_review (status,approval_date,contact_name,contact_address,contact_phone,contact_email)>
<!ELEMENT status (#PCDATA)><!-- Not approved,Approved,NA -->
<!ELEMENT approval_date (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT contact_name (#PCDATA)>
<!ELEMENT contact_address (#PCDATA)>
<!ELEMENT contact_phone (#PCDATA)>
<!ELEMENT contact_email (#PCDATA)>
]>
<trials>
  <trial>
    <main>
      <trial_id>IRCT20201013049017N3</trial_id>
      <utrn></utrn>
      <reg_name>IRCT</reg_name>
      <date_registration>2022-10-12</date_registration>
      <primary_sponsor>Esfahan University of Medical Sciences</primary_sponsor>
      <public_title>Evaluation of the time of cholecystectomy after ERCP</public_title>
      <acronym></acronym>
      <scientific_title>Evaluation of the outcomes of early cholecystectomy compared to delayed cholecystectomy after ERCP</scientific_title>
      <scientific_acronym></scientific_acronym>
      <date_enrolment>2022-09-23</date_enrolment>
      <type_enrolment>anticipated</type_enrolment>
      <target_size>188</target_size>
      <recruitment_status>Complete</recruitment_status>
      <url>https://irct.ir/trial/63670</url>
      <study_type>interventional</study_type>
      <study_design>Randomization: Randomized, Blinding: Single blinded, Placebo: Not used, Assignment: Parallel, Purpose: Treatment, Randomization description: For sampling, the method of double random blocks with SPSS software is used. In this way, two people who come for surgery are considered as one block until the number of blocks reaches 94. Then one person from each block is randomly assigned by the early method and one person by the delayed method, Blinding description: Participants are randomly assigned to receive one type of intervention, and only researchers know which participants are in which group, but participants do not know.</study_design>
      <phase>N/A</phase>
      <hc_freetext>Cholecystitis,Choldocolithiasis.</hc_freetext>
      <i_freetext>Intervention 1: The first intervention group: early cholecystectomy - in this group, the time interval between ERCP and cholecystectomy is less than 6 days. All patients are NPO 6 hours before the operation. Vital signs, heart monitoring and routine tests will be done for all patients.Laparoscopic cholecystectomy operation will be performed as 4 ports (subxiphoid, preumbilical ports with 10 mm incisions, midclavicular and anterior axillary ports with 5 mm incisions). The rate of conversion of laparoscopic surgery to open surgery, the amount of bleeding, the average duration of surgery, the amount of damage to viscera and bile ducts during the operation will be recorded. The average duration of hospitalization and the amount of bile leakage from the drain after surgery will be extracted from his file and recorded. The rate of need for repeat ERCP and the rate of infection at the surgical site after the operation will also be recorded through the follow-up of the patient's condition. After recording the extracted data and statistical analysis, the obtained results will be analyzed and written. Intervention 2: The second intervention group: late cholecystectomy - in this group, the time interval between ERCP and cholecystectomy is more than 6 days. All patients are NPO 6 hours before the operation. Vital signs, heart monitoring and routine tests will be done for all patients.Laparoscopic cholecystectomy operation will be performed as 4 ports (subxiphoid, preumbilical ports with 10 mm incisions, midclavicular and anterior axillary ports with 5 mm incisions). The rate of conversion of laparoscopic surgery to open surgery, the amount of bleeding, the average duration of surgery, the amount of damage to viscera and bile ducts during the operation will be recorded. The average duration of hospitalization and the amount of bile leakage from the drain after surgery will be extracted from his file and recorded. The rate of need for repeat ERCP and the rate of infection at the surgical site after the operation will also be recorded through the follow-up of the patient's condition. After recording the extracted data and statistical analysis, the obtained results will be analyzed and written.</i_freetext>
      <results_actual_enrolment></results_actual_enrolment>
      <results_date_completed></results_date_completed>
      <results_url_link></results_url_link>
      <results_summary></results_summary>
      <results_date_posted></results_date_posted>
      <results_date_first_publication></results_date_first_publication>
      <results_baseline_char></results_baseline_char>
      <results_participant_flow></results_participant_flow>
      <results_adverse_events></results_adverse_events>
      <results_outcome_measures></results_outcome_measures>
      <results_url_protocol></results_url_protocol>
      <results_IPD_plan>Yes - There is a plan to make this available</results_IPD_plan>
      <results_IPD_description>What will be shared:
All data is potentially shareable after deidentifying individuals

When:
The access period starts after the results are printed

To whom:
People who are engaged in the industry can apply for them.

Conditions:
In all circumstances

Where to obtain:
Internet networks

How to obtain:
By search

Comments:
</results_IPD_description>
    </main>
    <contacts>
      <contact>
        <type>public</type>
        <firstname>Hamid Talebzadeh</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Hezarjerib Ave, Isfahan University of Medical Sciences</address>
        <city>Isfahan</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>8174673461</zip>
        <telephone>+98 31 3668 0048</telephone>
        <email>Talebzadeh.h@med.mui.ac.ir</email>
        <affiliation>Esfahan University of Medical Sciences</affiliation>
      </contact>
      <contact>
        <type>scientific</type>
        <firstname>Hamid Talebzadeh</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Hezarjerib Ave, Isfahan University of Medical Sciences</address>
        <city>Isfahan</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>8174673461</zip>
        <telephone>+98 31 3668 0048</telephone>
        <email>Talebzadeh.h@med.mui.ac.ir</email>
        <affiliation>Esfahan University of Medical Sciences</affiliation>
      </contact>
    </contacts>
    <countries>
      <country2>Iran (Islamic Republic of)</country2>
      <country2>Iran (Islamic Republic of)</country2>
    </countries>
    <criteria>
      <inclusion_criteria>Patients over 18 years old with coledocolitiasis who are candidates for ERCP and then cholecystectomy</inclusion_criteria>
      <agemin>18 years</agemin>
      <agemax>no limit</agemax>
      <gender>Both</gender>
      <exclusion_criteria>Intolerance to general anesthesia
Severe liver and kidney dysfunction
Patients who refuse surgery
Occurrence of pancreatitis after ERCP</exclusion_criteria>
    </criteria>
    <health_condition_code>
      <hc_code>K80.5</hc_code>
    </health_condition_code>
    <health_condition_keyword>
      <hc_keyword>Calculus of bile duct without cholangitis or cholecystitis</hc_keyword>
    </health_condition_keyword>
    <intervention_code>
      <i_code>Treatment - Surgery</i_code>
      <i_code>Treatment - Surgery</i_code>
    </intervention_code>
    <intervention_keyword>
      <i_keyword>The first intervention group: early cholecystectomy - in this group, the time interval between ERCP and cholecystectomy is less than 6 days. All patients are NPO 6 hours before the operation. Vital signs, heart monitoring and routine tests will be done for all patients.Laparoscopic cholecystectomy operation will be performed as 4 ports (subxiphoid, preumbilical ports with 10 mm incisions, midclavicular and anterior axillary ports with 5 mm incisions). The rate of conversion of laparoscopic surgery to open surgery, the amount of bleeding, the average duration of surgery, the amount of damage to viscera and bile ducts during the operation will be recorded. The average duration of hospitalization and the amount of bile leakage from the drain after surgery will be extracted from his file and recorded. The rate of need for repeat ERCP and the rate of infection at the surgical site after the operation will also be recorded through the follow-up of the patient's condition. After recording the extracted data and statistical analysis, the obtained results will be analyzed and written.</i_keyword>
      <i_keyword>The second intervention group: late cholecystectomy - in this group, the time interval between ERCP and cholecystectomy is more than 6 days. All patients are NPO 6 hours before the operation. Vital signs, heart monitoring and routine tests will be done for all patients.Laparoscopic cholecystectomy operation will be performed as 4 ports (subxiphoid, preumbilical ports with 10 mm incisions, midclavicular and anterior axillary ports with 5 mm incisions). The rate of conversion of laparoscopic surgery to open surgery, the amount of bleeding, the average duration of surgery, the amount of damage to viscera and bile ducts during the operation will be recorded. The average duration of hospitalization and the amount of bile leakage from the drain after surgery will be extracted from his file and recorded. The rate of need for repeat ERCP and the rate of infection at the surgical site after the operation will also be recorded through the follow-up of the patient's condition. After recording the extracted data and statistical analysis, the obtained results will be analyzed and written.</i_keyword>
    </intervention_keyword>
    <primary_outcome>
      <prim_outcome>Local infection. Timepoint: 7 days after surgery. Method of measurement: File Reading and Physical Examination.</prim_outcome>
      <prim_outcome>Duration of surgery. Timepoint: During surgery. Method of measurement: File Reading.</prim_outcome>
      <prim_outcome>Bleeding during surgery. Timepoint: During surgery. Method of measurement: File Reading.</prim_outcome>
      <prim_outcome>Conversion to open surgery. Timepoint: During Surgery. Method of measurement: File reading.</prim_outcome>
      <prim_outcome>Bile leakage from the drain. Timepoint: one day after the surgery. Method of measurement: File Reading.</prim_outcome>
      <prim_outcome>Damage to internal organs and bile ducts. Timepoint: During surgery. Method of measurement: File reading.</prim_outcome>
      <prim_outcome>Need for repeat ERCP. Timepoint: 7 days after surgery. Method of measurement: File Reading and Physical Examination.</prim_outcome>
      <prim_outcome>Duration of hospitalization. Timepoint: 7 days after surgery. Method of measurement: File reading.</prim_outcome>
    </primary_outcome>
    <secondary_outcome>
      <sec_outcome></sec_outcome>
    </secondary_outcome>
    <secondary_sponsor>
      <sponsor_name></sponsor_name>
    </secondary_sponsor>
    <secondary_ids>
      <secondary_id>
        <sec_id></sec_id>
        <issuing_authority></issuing_authority>
      </secondary_id>
    </secondary_ids>
    <source_support>
      <source_name>Esfahan University of Medical Sciences</source_name>
    </source_support>
    <ethics_reviews>
      <ethics_review>
        <status>Approved</status>
        <approval_date>2022-03-08</approval_date>
        <contact_name>Ethics committee of Isfahan University of Medical Sciences</contact_name>
        <contact_address>Sofeh Blvd,Al-Zahra Hospital Isfahan Isfehan Iran (Islamic Republic of)</contact_address>
        <contact_phone></contact_phone>
        <contact_email></contact_email>
      </ethics_review>
    </ethics_reviews>
  </trial>
</trials>
